The acquired immune deficiency syndrome (AIDS) is now widespread in patients with haemophilia (type A more than type B) due to contamination of blood products with human immunodeficiency virus (HIV).1 2 Those infected in this way showed anti-HIV antibodies in their serum,3 T4 lymphopenia,4 and cutaneous anergy similar to that seen in patients infected by other routes.5 T4 lymphopenia and diminished responsiveness to dinitrochlorobenzene sensitisation occur in such patients not infected with HIV, and it is thought that repeated administration of large amounts of factor VIII or cryoprecipitate may itself be immunosuppressive. 6 In this study apparent cutaneous anergy to commonly encountered bacterial antigens in some haemophilia A patients reflects lack of prophylactic immunisation rather than immunosuppression: other assessments of immune function were apparently normal.
Material and methods
Fifteen patients with factor VIII deficiency (12 with haemophilia A and three with von Willebrand's disease) and five patients with factor IX deficiency were The antibody titres to cytomegalovirus, herpes simplex, herpes zoster and Toxoplasma in the patients with inherited coagulation defects were not significantly different from those in the controls. Twelve of the 20 patients had antibodies to HBs and HBc as did one of the controls. All controls had positive tests for IgG antibody specific for Epstein-Barr virus (EBV) but were negative to IgM antibody (indicating past infection). Of the 16 patients with IgG antibodies to EBV, six also gave a positive test for IgM antibodies (suggesting initially that these patients had active infection), but these results must be regarded as false positives as the sera became negative after absorption with aggregated human IgG. It is therefore likely that the false positive results were due to the presence of "rheumatoid factor" or related IgM class anti-IgG antibody.
Tests for antibody to HIV were performed in 1985 on serum samples removed at the time of skin testing (radioimmunoassay by Dr RS Tedder) and samples removed one year later, 1986 (ELISA). All these serum samples were negative for anti-HIV.
Discussion
The absence of skin test responses in the group with haemophilia A occurred in those patients who had not been vaccinated and with those antigens generally only encountered at immunisation. Skin test responses to other antigens were comparable in all groups. Thus the non-reactors were not immunosuppressed, merely unimmunised. The reason why they did not receive immunisation cannot be established at this late date. It may have been due to the natural desire of the parents to protect them from responded to common pathogens by specific antibody production. The high prevalence of antibodies to hepatitis B virus indicates an appropriate humoral response to the frequent contamination of coagulation factor concentrates with virus antigen. It is important to note the high prevalence of false positive results in the tests for IgM antibodies to EBV, lest an incorrect assumption be made of persisting or reactivation of EBV infection.
Five of the 12 haemophilia A patients showed some degree of lymphopenia. All had been treated with factor VIII concentrate that can be assumed to have been free from contamination with HIV; none had evidence of antibody to this virus either at the time of immunological study or more than one year later.
This accords with other studies of haemophilia A patients not infected with HIV where T4 lymphopenia has been attributed to large quantities of factor VIII per se. 6 This study shows that in this group of patients apparent cutaneous anergy should be interpreted with caution as it may reflect non-immunisation rather than immunosuppression.
